Search - tctmd.com

Displaying 21 - 40 of 168

Sort: Relevancy | Date

News Daily News

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Michael O'Riordan

October 10, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

Presentation ACC 2024

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Presenter: Seung-Jung Park

April 07, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

L.A. McKeown

February 06, 2024

Presentation Miami Valves 2024

Coronary Imaging: The Data is Clear

Presenter: Michael D Dyal

February 03, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Caitlin E. Cox

December 07, 2023

News Daily News

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Michael O'Riordan

November 24, 2023

News Conference News TCT 2023

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Todd Neale

October 23, 2023

Presentation ESC 2023

Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided PCI: The OCTIVUS Randomized Clinical Trial

Presenter: Duk-Woo Park

August 28, 2023

News Daily News

IVUS in Complex PCI Improves Outcomes, Even for Less-Experienced Operators

Caitlin E. Cox

July 27, 2023

News Daily News

Cath Lab Garbage: ‘What Are We Going to Do About It?’

Michael O'Riordan

May 08, 2023

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

Presentation ACC 2023

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

Presenter: Annapoorna S. Kini

March 06, 2023

Presentation ACC 2023

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Presenter: Roberto Diletti

March 05, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

Advertisement

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

Coronary Imaging: The Data is Clear

February 2024 Dispatch for the CV Team

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

AHA Selects 2023’s Leading Cardiovascular Research

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions

Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided PCI: The OCTIVUS Randomized Clinical Trial

IVUS in Complex PCI Improves Outcomes, Even for Less-Experienced Operators

Cath Lab Garbage: ‘What Are We Going to Do About It?’

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content